Pulmonary Arterial Hypertension and Cancer: An Update on Their Similarities

References (117)

1. 1 The Hallmarks of Cancer [DOI]
2. 2 Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis [DOI]
3. 3 HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia [DOI]
4. 4 A microRNA polycistron as a potential human oncogene [DOI]
5. 5 Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis [DOI]
6. 6 Clinical classification of pulmonary hypertension [DOI]
7. 7 IAP proteins: blocking the road to death's door [DOI]
8. 8 Cellular and molecular pathobiology of pulmonary arterial hypertension [DOI]
9. 9 Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis [DOI]
10. 10 Validating survivin as a cancer therapeutic target [DOI]
11. 11 Diagnosis and differential assessment of pulmonary arterial hypertension [DOI]
12. 12 TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights [DOI]
13. 13 Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
14. 14 Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia [DOI]
15. 15 How Tumors Become Angiogenic [DOI]
16. 16 Imatinib for the Treatment of Pulmonary Arterial Hypertension [DOI]
17. 17 Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. [DOI]
18. 18 Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy [DOI]
19. 19 Dichloroacetate, a Metabolic Modulator, Prevents and Reverses Chronic Hypoxic Pulmonary Hypertension in Rats [DOI]
20. 20 Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer [DOI]
21. 21 An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension [DOI]
22. 22 Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline [DOI]
23. 23 Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 ( ALK1 ) Mutation [DOI]
24. 24 Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation [DOI]
25. 25 Suppressing Cancer: The Importance of Being Senescent [DOI]
26. 26 Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents [DOI]
27. 27 The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension [DOI]
28. 28 Plexiform Lesions in Pulmonary Arterial Hypertension [DOI]
29. 29 Pulmonary Hypertension Due to BMPR2 Mutation: A New Paradigm for Tissue Remodeling? [DOI]
30. 30 THE PATHOBIOLOGY OF PULMONARY HYPERTENSION [DOI]
31. 31 miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer [DOI]
32. 32 Impaired Apoptosis of Pulmonary Endothelial Cells Is Associated With Intimal Proliferation and Irreversibility of Pulmonary Hypertension in Congenital Heart Disease [DOI]
33. 33 Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension [DOI]
34. 34 Mir-206 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation and Differentiation [DOI]
35. 35 Primary Pulmonary Hypertension Between Inflammation and Cancer [DOI]
36. 36 Mortality and immortality at the cellular level. A review.
37. 37 Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy [DOI]
38. 38 Apoptosis and micro RNA aberrations in cancer [DOI]
39. 39 The Role of Na+/H+ Exchange and Growth Factors in Pulmonary Artery Smooth Muscle Cell Proliferation [DOI]
40. 40 Fibroblast Growth Factor-2 Expression Is Altered in Lambs With Increased Pulmonary Blood Flow and Pulmonary Hypertension [DOI]
41. 41 Role of Phosphorylation in the Control of Clathrin-Mediated Internalization of GPCR [DOI]
42. 42 Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. [DOI]
43. 43 Pulmonary arterial hypertension in children: a medical update [DOI]
44. 44 Bosentan for the Treatment of Adult Pulmonary Hypertension [DOI]
45. 45 Pulmonary arterial hypertension in children: A Medical Update [DOI]
46. 46 Lessons from oncology to understand and treat pulmonary hypertension [DOI]
47. 47 056 Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease [DOI]
48. 48 404-4 Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy [DOI]
49. 49 Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension [DOI]
50. 50 Inhibition Of MicroRNA-17 Improves Lung And Heart Function In Experimental Pulmonary Hypertension [DOI]
51. 51 Hallmarks of Cancer: The Next Generation [DOI]
52. 52 On the Origin of Cancer Cells [DOI]
53. 53 Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene [DOI]
54. 54 Why do cancers have high aerobic glycolysis? [DOI]
55. 55 THE METABOLISM OF TUMORS IN THE BODY [DOI]
56. 56 Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation [DOI]
57. 57 A microRNA component of the p53 tumour suppressor network [DOI]
58. 58 Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor [DOI]
59. 59 Pathological roles of MAPK signaling pathways in human diseases [DOI]
60. 60 GROWTH FACTOR RECEPTOR TYROSINE KINASES [DOI]
61. 61 NFAT proteins: key regulators of T-cell development and function [DOI]
62. 62 A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth [DOI]
63. 63 Reversal of experimental pulmonary hypertension by PDGF inhibition [DOI]
64. 64 Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells [DOI]
65. 65 Pulmonary Arterial Hypertension in Patients Treated by Dasatinib [DOI]
66. 66 Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension [DOI]
67. 67 Role for miR-204 in human pulmonary arterial hypertension [DOI]
68. 68 Reversible Cellular Senescence: Implications for Immortalization of Normal Human Diploid Fibroblasts [DOI]
69. 69 PDGF receptors as cancer drug targets [DOI]
70. 70 Hypoxic pulmonary vasoconstriction [DOI]
71. 71 Activation of Glycogen Synthase Kinase 3β Disrupts the Binding of Hexokinase II to Mitochondria by Phosphorylating Voltage-Dependent Anion Channel and Potentiates Chemotherapy-Induced Cytotoxicity [DOI]
72. 72 Alterations of cellular bioenergetics in pulmonary artery endothelial cells [DOI]
73. 73 Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension [DOI]
74. 74 The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted [DOI]
75. 75 Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases [DOI]
76. 76 Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival [DOI]
77. 77 The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle [DOI]
78. 78 Pathobiology of Pulmonary Hypertension [DOI]
79. 79 The Cancer Paradigm of Severe Pulmonary Arterial Hypertension [DOI]
80. 80 Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells [DOI]
81. 81 Fatty Acid Oxidation and Malonyl-CoA Decarboxylase in the Vascular Remodeling of Pulmonary Hypertension [DOI]
82. 82 Inhibition of MicroRNA-17 Improves Lung and Heart Function in Experimental Pulmonary Hypertension [DOI]
83. 83 Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms [DOI]
84. 84 Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension [DOI]
85. 85 Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension [DOI]
86. 86 p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice [DOI]
87. 87 A Dosing/Cross-Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension [DOI]
88. 88 Delta‐tocotrienol suppresses Notch‐1 pathway by upregulating miR‐34a in nonsmall cell lung cancer cells [DOI]
89. 89 Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing [DOI]
90. 90 Vascular remodeling in pulmonary arterial hypertension: Multiple cancer-like pathways and possible treatment modalities [DOI]
91. 91 HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism [DOI]
92. 92 Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension [DOI]
93. 93 VEGF‐R blockade causes endothelial cell apoptosis, expansion of surviving CD34 + precursor cells and transdifferentiation to smooth muscle‐like and neuronal‐like cells [DOI]
94. 94 MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme [DOI]
95. 95 BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK [DOI]
96. 96 Bone Morphogenetic Protein Type II Receptor Mutations Causing Protein Misfolding in Heritable Pulmonary Arterial Hypertension [DOI]
97. 97 Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells [DOI]
98. 98 Novel Strategy for Treatment of Pulmonary Arterial Hypertension: Enhancement of Apoptosis [DOI]
99. 99 Pulmonary arterial hypertension and statins: an update [DOI]
100. 100 Hypoxic Pulmonary Vasoconstriction [DOI]
101. 101 Updated Clinical Classification of Pulmonary Hypertension [DOI]
102. 102 Updated Clinical Classification of Pulmonary Hypertension [DOI]
103. 103 Multifaceted roles of glycolytic enzymes [DOI]
104. 104 An Abnormal Mitochondrial–Hypoxia Inducible Factor-1α–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats [DOI]
105. 105 The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell Lines [DOI]
106. 106 Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension [DOI]
107. 107 Updated Clinical Classification of Pulmonary Hypertension [DOI]
108. 108 Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension [DOI]
109. 109 Autoimmunity and pulmonary hypertension: a perspective [DOI]
110. 110 A microRNA polycistron as a potential human oncogene [DOI]
111. 111 Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension [DOI]
112. 112 Evaluation of Imatinib Mesylate in the Treatment of Pulmonary Arterial Hypertension [DOI]
113. 113 Polyamines and Epidermal Growth Factor in Monocrotaline-induced Pulmonary Hypertension [DOI]
114. 114 Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation [DOI]
115. 115 Role for miR-204 in human pulmonary arterial hypertension [DOI]
116. 116 DYNAMIC CHANGES OF GENE EXPRESSION IN HYPOXIA-INDUCED RIGHT VENTRICULAR HYPERTROPHY. [DOI]
117. 117 Hypoxic Pulmonary Vasoconstriction [DOI]

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Characterization of the Biochemical Pathway of Apoptosis Induced by D-glucopyranoside Derivatives from Tulbaghia violacea — shares topic coverage
• Fetal Myocardial Reduction in Hyperglycemic Mouse Pregnancy is Associated with Dys-regulated Expression of the Anti-apoptotic Gene Bcl-2 in the Developing Heart. Preliminary Results — shares topic coverage
• Periodontitis: A Cellular Tactic to Escape Cancer — shares topic coverage
• Protective Effect of Artemisia judaica against Doxorubicin-Induced Toxicity in Mice — shares topic coverage
• Induction of Mitochondrial-Mediated Apoptosis by Solvent Fractions of Methanol Extract of Heliotropium indicum in Rat Liver Cells — shares topic coverage